Table 3.
Baseline, follow-up, and changes in the symptomatic and functional scales for patients with available baseline and follow-up data (group A: bone marrow concentrate (BMC), group B: BMC and adipose graft, LEFS: lower extremity functional scale, NPS: numeric pain scale, SD: standard deviation, and ∗indicates a statistically significant difference between groups).
| Group A | Group B | P value | |||
|---|---|---|---|---|---|
| N | Mean (SD) | N | Mean (SD) | ||
| Clinical scales | |||||
| Improvement rating scale | 408 | 46.8 (38) | 166 | 39.3 (39.8) | 0.030∗ |
| LEFS (baseline) | 205 | 46.1 (15.8) | 91 | 43.6 (14.9) | — |
| LEFS (follow-up) | 205 | 54 (17.9) | 91 | 53.4 (14.7) | — |
| NPS (baseline) | 220 | 4 (2.3) | 103 | 4.3 (2.0) | — |
| NPS (follow-up) | 220 | 2.6 (2.3) | 103 | 3 (2.3) | — |
| Changes from the baseline | |||||
| Change in LEFS | 205 | 7.9 (16.1) | 91 | 9.8 (14.2) | 0.335 |
| Change in NPS | 220 | −1.4 (2.6) | 103 | −1.3 (2.5) | 0.761 |
| Follow-up (in months) | |||||
| Improvement rating scale | 408 | 10.4 (9.4) | 166 | 10.7 (8.1) | — |
| LEFS | 205 | 6.2 (5.0) | 91 | 5.7 (3.8) | — |
| NPS | 220 | 7 (6.6) | 103 | 6.7 (5.3) | — |